Cited 0 times in Scipus Cited Count

A double blind, placebo-controlled, randomized clinical trial that breast milk derived-Lactobacillus gasseri BNR17 mitigated diarrhea-dominant irritable bowel syndrome

DC Field Value Language
dc.contributor.authorShin, SP-
dc.contributor.authorChoi, YM-
dc.contributor.authorKim, WH-
dc.contributor.authorHong, SP-
dc.contributor.authorPark, JM-
dc.contributor.authorKim, J-
dc.contributor.authorKwon, O-
dc.contributor.authorLee, EH-
dc.contributor.authorHahm, KB-
dc.date.accessioned2019-11-13T00:17:47Z-
dc.date.available2019-11-13T00:17:47Z-
dc.date.issued2018-
dc.identifier.issn0912-0009-
dc.identifier.urihttp://repository.ajou.ac.kr/handle/201003/16751-
dc.description.abstractThe exact pathogenesis of diarrhea-dominant irritable bowel syndrome (IBS) is not known, but the abnormal microbiota of the gastrointestinal tract is considered to be one of the important contributing factors as in other gastrointestinal diseases such as inflammatory bowel disease, antibiotic-associated diarrhea, and colorectal cancer as well as systemic diseases. Though diverse trials of probiotics had been continued in the treatment of diarrhea-IBS, only a few proved by randomized clinical trial. To prove the efficacy of Lactobacillus gasseri BNR17 isolated from breast milk in patients with diarrhea-IBS, prospective, randomized, placebo controlled clinical trial was done including health related-quality of life analysis, colon transit time, and the changes of fecal microbiota. BNR17 significantly improved the symptoms of diarrhea compared to control group. Health related-QOL analysis showed significant improvement of abdominal pain, distension, disturbed daily life, and mean defecation frequency with BNR17. On comparative CTT before and after BNR17, 6 out of 24 subjects showed significant correction of rapid colon transit pattern, while only 2 out of 24 in placebo (p<0.01). Upon fecal microbiota analysis, BNR17 significantly increased B. fecalis, E. rectale, C. aerofaciens, F. prausnitzil and B. steroris. Conclusively, Lactobacillus gasseri BNR17 can be a potential probiotics to ameliorate diarrhea-IBS.-
dc.language.isoen-
dc.titleA double blind, placebo-controlled, randomized clinical trial that breast milk derived-Lactobacillus gasseri BNR17 mitigated diarrhea-dominant irritable bowel syndrome-
dc.typeArticle-
dc.identifier.pmid29610559-
dc.identifier.urlhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874236/-
dc.subject.keywordIBS-QOL-
dc.subject.keywordLactobacillus gasseri BNR17-
dc.subject.keywordcolon transit time-
dc.subject.keyworddiarrhea-dominant IBS-
dc.subject.keywordmicrobiota-
dc.contributor.affiliatedAuthor이, 은현-
dc.type.localJournal Papers-
dc.identifier.doi10.3164/jcbn.17-73-
dc.citation.titleJournal of clinical biochemistry and nutrition-
dc.citation.volume62-
dc.citation.number2-
dc.citation.date2018-
dc.citation.startPage179-
dc.citation.endPage186-
dc.identifier.bibliographicCitationJournal of clinical biochemistry and nutrition, 62(2). : 179-186, 2018-
dc.identifier.eissn1880-5086-
dc.relation.journalidJ009120009-
Appears in Collections:
Journal Papers > Graduate School of Public Health > Public Health
Files in This Item:
29610559.pdfDownload

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse